Equity
€338,220 ▲ 5.8%
PhilClapharma has made a profit in every financial year since 2018.
PhilClapharma
Lifetime
8 annual accounts with figures on one time axispeak €98,511 (2018)
€54,060▼ 21.5%
peak €53,706 (2018)
€18,464▼ 50.0%
peak €338,220 (2025)
€338,220▲ 5.8%
€529,712▼ 3.7%
Board1 name since 2017
1 director
Documentsfilings and deeds
29-06-202632 days before the deadline
2025micro format
Gross margin from €68,833 to €54,060Result from €36,909 to €18,464
Key points
from the 2025 annual accountsFilings
8 annual accounts 2 late
The 2018 accounts came latest: 29 days after the end of the period.
Position in the sector
€338,220
More equity than 91% of companies in retail trade. Sector median €40,895 · 25,314 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0675782469
Change of role: , from manager to director
General meeting of 30-12-2023 · Gazette deed
First establishment
Brusselsesteenweg 77, Tervuren
Incorporation
Founding capital of €30,000, 100 shares · Founder: (verschijnster/oprichter) · Appointment: (manager) · published on 19-05-2017 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PhilClapharma Tervuren | €0.9m | €54,060 | 39.0% | - |
| FRAPEJA PHARMA Ghent | €0.8m | €53,628 | 17.6% | 0 |
| Apotheek Berckenbosch Leuven | €0.7m | €64,957 | 14.5% | - |
| MYLLE PHARMA Anzegem | €0.9m | €68,478 | 50.5% | - |
| Philotheek Antwerp | €1.1m | €77,883 | 41.3% | - |
| VdC Invest Lierde | €0.7m | €72,241 | 48.2% | - |
| Apotheek Naegels Tremelo | €0.7m | €85,528 | 32.9% | - |
These companies have the same main activity as PhilClapharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €653,000 and €1.1m, founded between 2014 and 2018.
Official details
Source: KBO- Status
- Active since 17-05-2017Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Establishment unit
- 2.265.203.2873080 Tervuren, since 01-07-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 08-09-2025
Annual accounts 2025
- ≈ €260,000estimated
- €867,932▼ 0.2%
- Filing
- Filed on 29-06-2026, 32 days before the end of the filing period
Insights on PhilClapharma
PhilClapharma files the micro format. That format states no turnover. The gross margin fell from €98,511 in 2018 to €54,060 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PhilClapharma
- What is the company number of PhilClapharma?
- The company number of PhilClapharma is 0675.782.469. The VAT number is the same number with BE in front: BE 0675.782.469.
- Where is PhilClapharma based?
- The registered office is at Brusselsesteenweg 77, 3080 Tervuren.Company details
- What does PhilClapharma do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of PhilClapharma?
- PhilClapharma is a private limited company (BV).
- When was PhilClapharma founded?
- PhilClapharma was founded on 17-05-2017.
- Is PhilClapharma still active?
- Yes, PhilClapharma is an active enterprise in the KBO register.
- What is the turnover of PhilClapharma?
- The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €54,060 and 54 comparable companies (NACE 477). It probably lies between €130,000 and €380,000.Financials
- Is PhilClapharma profitable?
- In financial year 2025, PhilClapharma made a profit of €18,464.
- Where can I find the annual accounts of PhilClapharma?
- PhilClapharma filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PhilClapharma due?
- PhilClapharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.